Evolent Health, Inc. (EVH) News
Track canonical SquawkNews coverage tagged to EVH, Evolent Health, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
EVH - TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation
EVH - TransPerfect Selected by Evolent for Enterprise-Wide Telephonic Interpretation
NEWS | Sep 21, 2026, 02:02 PM UTC
L
Evolent Health Raises FY2026 Sales Guidance from $2.400B-$2.600B to $2.600B-$2.700B vs $2.503B Est
Evolent Health (NYSE: EVH ) raises FY2026 sales outlook from $2.400 billion-$2.600 billion to $2.600 billion-$2.700 billion vs $2.503 billion estimate.
EARNINGS | Aug 06, 2026, 11:06 AM UTC
L
EVH - Evolent Announces Second Quarter 2026 Results
EVH - Evolent Announces Second Quarter 2026 Results
EARNINGS | Aug 06, 2026, 11:01 AM UTC
L
EVH Downgrade from Buy to Neutral at Citi
EVH Downgrade from Buy to Neutral at Citi
EQUITY | Jul 23, 2026, 11:55 AM UTC
L
Evolent Health shares are trading lower after Truist Securities downgraded the stock from Buy to Hold rating and maintained the price target
Evolent Health shares are trading lower after Truist Securities downgraded the stock from Buy to Hold rating and maintained the price target at $7.
EQUITY | Jun 30, 2026, 02:08 PM UTC
L
Truist Securities Downgrades Evolent Health to Hold, Maintains Price Target to $7
Truist Securities analyst Jailendra Singh downgrades Evolent Health (NYSE: EVH ) from Buy to Hold and maintains the price target from $7 to $7.
EQUITY | Jun 30, 2026, 01:51 PM UTC